Effects of Dopamine Antagonists on Drug Cue-induced Reinstatement of Nicotine-seeking Behavior in Rats

Overview

Journal Behav Pharmacol

Specialties Pharmacology
Psychology
Social Sciences

Date 2010 Feb 20

PMID 20168211

Citations 33

Authors

Xiu Liu

Courtney Jernigen

Maysa Gharib

Sheri Booth

Anthony R Caggiula

Alan F Sved

Affiliations

Soon will be listed here.

Abstract

Dopaminergic neurotransmission has been implicated in associative learning processes related to drugs of abuse. However, it is not clear whether blockade of activation of dopamine receptors alters conditioned incentive properties of nicotine-associated cues. Using a response-reinstatement procedure, this study examined the effects of antagonists selective for the D1 and the D2 subtypes of dopamine receptors on cue-induced reinstatement of nicotine-seeking behavior. Male Sprague-Dawley rats were trained in 30 daily 1 h sessions to intravenously self-administer nicotine (0.03 mg/kg/infusion) on a fixed ratio 5 schedule and associate a conditioned stimulus (cue) with each nicotine delivery. After extinction of responding by withholding nicotine (saline substitution) and its cue, the reinstatement tests were conducted following subcutaneous administration of a D1 antagonist SCH23390 (0, 5, 10, 30 microg/kg) or a D2 antagonist eticlopride (0, 5, 10, 30 microg/kg) in different groups of animals. Both SCH23390 and eticlopride significantly attenuated the magnitude of cue-elicited reinstatement of nicotine-seeking responding. These results indicate that activation of dopaminergic D1 and D2 receptors may play a role in mediating the conditioned motivational effects of nicotine-associated cues as measured in the response-reinstatement procedure. These findings suggest that manipulation of dopaminergic neurotransmission at D1 and/or D2 receptors may prove to be a potential target for the development of pharmacotherapy for prevention of environmental nicotine cue-triggered smoking relapse.

Citing Articles

The ventral tegmental area dopamine to basolateral amygdala projection supports acquisition of cocaine self-administration.

Smith D, Torregrossa M Neuropharmacology. 2024; 261:110160.

PMID: 39293506 PMC: 11585075. DOI: 10.1016/j.neuropharm.2024.110160.

Hypocretin-1 receptor antagonism improves inhibitory control during the Go/No-Go task in highly motivated, impulsive male mice.

Metha J, Ji Y, Braun C, Nicholson J, De Lecea L, Murawski C Psychopharmacology (Berl). 2024; 241(10):2171-2187.

PMID: 38886189 PMC: 11442560. DOI: 10.1007/s00213-024-06628-3.

Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.

Herman R, Schmidt H Physiol Behav. 2024; 281:114565.

PMID: 38663460 PMC: 11128349. DOI: 10.1016/j.physbeh.2024.114565.

The involvement of dopamine and D2 receptor-mediated transmission in effects of cotinine in male rats.

Tan X, Neslund E, Ding Z Neuropharmacology. 2023; 230:109495.

PMID: 36914092 PMC: 10071274. DOI: 10.1016/j.neuropharm.2023.109495.

The D1/D2-like receptor antagonist flupentixol and the D2-like receptor antagonist L-741626 decrease operant responding for nicotine and food and locomotor activity in male and female rats.

Chellian R, Behnood-Rod A, Wilson R, Lin K, King G, Bruijnzeel A J Psychopharmacol. 2023; 37(2):216-228.

PMID: 36680471 PMC: 10704414. DOI: 10.1177/02698811221147141.

References

Gasior M, Shoaib M, Yasar S, Jaszyna M, Goldberg S . Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine. J Pharmacol Exp Ther. 1999; 288(3):1053-73. View

McBride D, Barrett S, Kelly J, Aw A, Dagher A . Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study. Neuropsychopharmacology. 2006; 31(12):2728-38. DOI: 10.1038/sj.npp.1301075. View

Corrigall W, Franklin K, Coen K, CLARKE P . The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl). 1992; 107(2-3):285-9. DOI: 10.1007/BF02245149. View

Niaura R, Abrams D, Demuth B, Pinto R, Monti P . Responses to smoking-related stimuli and early relapse to smoking. Addict Behav. 1989; 14(4):419-28. DOI: 10.1016/0306-4603(89)90029-4. View

Schroeder B, Binzak J, Kelley A . A common profile of prefrontal cortical activation following exposure to nicotine- or chocolate-associated contextual cues. Neuroscience. 2001; 105(3):535-45. DOI: 10.1016/s0306-4522(01)00221-4. View

David S, Munafo M, Johansen-Berg H, Smith S, Rogers R, Matthews P . Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry. 2005; 58(6):488-94. PMC: 4439461. DOI: 10.1016/j.biopsych.2005.04.028. View

Spina L, Fenu S, Longoni R, Rivas E, Di Chiara G . Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition. Psychopharmacology (Berl). 2005; 184(3-4):447-55. DOI: 10.1007/s00213-005-0211-4. View

Rohsenow D, Tidey J, Miranda R, McGeary J, Swift R, Hutchison K . Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers. Exp Clin Psychopharmacol. 2008; 16(3):215-22. DOI: 10.1037/1064-1297.16.3.215. View

Miranda Jr R, Rohsenow D, Monti P, Tidey J, Ray L . Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity. Addict Behav. 2007; 33(2):347-53. PMC: 2254225. DOI: 10.1016/j.addbeh.2007.09.011. View

10.

Brazell M, Mitchell S, Joseph M, Gray J . Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology. 1990; 29(12):1177-85. DOI: 10.1016/0028-3908(90)90042-p. View

11.

Niaura R, Rohsenow D, Binkoff J, Monti P, Pedraza M, Abrams D . Relevance of cue reactivity to understanding alcohol and smoking relapse. J Abnorm Psychol. 1988; 97(2):133-52. DOI: 10.1037//0021-843x.97.2.133. View

12.

Maisonneuve I, Mann G, Deibel C, Glick S . Ibogaine and the dopaminergic response to nicotine. Psychopharmacology (Berl). 1997; 129(3):249-56. DOI: 10.1007/s002130050187. View

13.

OBrien C, Childress A, Ehrman R, Robbins S . Conditioning factors in drug abuse: can they explain compulsion?. J Psychopharmacol. 1998; 12(1):15-22. DOI: 10.1177/026988119801200103. View

14.

Childress A, Hole A, Ehrman R, Robbins S, McLellan A, OBrien C . Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr. 1993; 137:73-95. View

15.

Damsma G, Day J, Fibiger H . Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur J Pharmacol. 1989; 168(3):363-8. DOI: 10.1016/0014-2999(89)90798-x. View

16.

Sayette M, Martin C, Wertz J, Shiffman S, Perrott M . A multi-dimensional analysis of cue-elicited craving in heavy smokers and tobacco chippers. Addiction. 2001; 96(10):1419-32. PMC: 2636555. DOI: 10.1080/09652140120075152. View

17.

Nisell M, Nomikos G, Svensson T . Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse. 1994; 16(1):36-44. DOI: 10.1002/syn.890160105. View

18.

McCullough L, Salamone J . Involvement of nucleus accumbens dopamine in the motor activity induced by periodic food presentation: a microdialysis and behavioral study. Brain Res. 1992; 592(1-2):29-36. DOI: 10.1016/0006-8993(92)91654-w. View

19.

Marshall D, Redfern P, Wonnacott S . Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem. 1997; 68(4):1511-9. DOI: 10.1046/j.1471-4159.1997.68041511.x. View

20.

Hutchison K, Rutter M, Niaura R, Swift R, Pickworth W, Sobik L . Olanzapine attenuates cue-elicited craving for tobacco. Psychopharmacology (Berl). 2004; 175(4):407-13. DOI: 10.1007/s00213-004-1837-3. View